News Focus
News Focus
Followers 467
Posts 26957
Boards Moderated 1
Alias Born 09/11/2006

Re: surf1944 post# 139

Thursday, 11/08/2012 8:59:22 AM

Thursday, November 08, 2012 8:59:22 AM

Post# of 14157
7:59AM EpiCept and Immune Pharmaceuticals agreed to merge (EPCT) 0.13 : Immune Pharmaceuticals, a privately held Israeli com, and EpiCept announced earlier that they have entered into a definitive merger agreement. The transaction is anticipated to close during the first quarter of 2013 and is subject to satisfaction of certain customary closing conditions, including the approval of a majority of EpiCept shareholders. The combined com, to be named Immune Pharmaceuticals, will be primarily focused on developing antibody therapeutics and other targeted drugs for the treatment of inflammatory diseases and cancer.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today